Health ❯Pharmaceuticals

Weight-Loss Drugs

Wegovy Mounjaro Novo Nordisk

Alphabet Appoints Anat Ashkenazi as New CFO Amid AI Expansion

Pfizer Halts Development of Twice-Daily Weight Loss Pill Due to Adverse Side Effects

Novo Nordisk Reports Record Profits as Demand for Weight Loss Drugs Wegovy and Ozempic Surges Amid Global Shortages and Rising Concerns over Illegal Market Sales

Novo Nordisk's Weight Loss Drug Wegovy Launches in UK Amid High Demand and Limited Supply

FDA Warns Against Using Off-Brand Versions of Popular Diabetes, Weight Loss Drugs